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Aortitis identified in approximately 12% of all thoracoabdominal aneurysms. The most common subtype of inflammatory
aortitis is giant cell aortitis, followed by lymphoplasmacytic aortitis. Inflammatory aortitis may occur in isolation or as
part of a systemic inflammatory disorder such as Takayasu arteritis, systemic lupus erythematosus, rheumatoid arthritis,
and giant cell arteritis. Aortitis has not been described in patients with Marfan syndrome. We report the case of a
32-year-old man with Marfan syndrome and a strong family history of aneurysmal disease who presented with an
asymptomatic Crawford type IV thoracoabdominal aneurysm. His aneurysm had no associated dissection, and surgical
pathology revealed severe medial degeneration and lymphoplasmacytic aortitis. To our knowledge, this is the first report
of such a finding in a patient with Marfan syndrome. (J Vasc Surg 2005;42:168-71.)Thoracic aortic aneurysms, dissections, and aortic rup-
ture are common cardiovascular manifestations of Marfan
syndrome (MFS).1 When compared with patients with
degenerative thoracoabdominal aneurysms (TAAs), pa-
tients with MFS have a higher incidence (50% vs 27.7%) of
more extensive aneurysms (Crawford type II),2 which in-
volve all or most of the descending thoracic and abdominal
aorta. Patients with MFS also have a higher incidence of
associated aortic dissections. (82% vs 21%).1 Aneurysms
that involve all or most of the abdominal aorta (Crawford
type IV) constitute approximately 18% of TAAs in patients
with MFS.1 Most of these aneurysms in patients with MFS
have a disruption of medial and adventitial elastin and
collagen in association with necrosis of the medial smooth
muscle cells and accumulation of proteoglycans, a histo-
logic lesion termed cystic medial degeneration (CMD).3,4
This noninflammatory lesion is associated with abnormal
fibrillin 1 synthesis due to a mutation in the FBN1 gene on
chromosome 15 in patients with MFS.3 An inflammatory
infiltrate of the aortic wall (aortitis) in aortic aneurysms is
uncommon. A recent 20-year review of pathologic speci-
mens from consecutive aortic surgeries revealed that only
52 of 1204 specimens (4.3%) were classified as idiopathic
aortitis, a designation that required exclusion of vasculitis
associated with postoperative infections, atherosclerosis, or
inflammation occurring around surgical materials from pre-
vious operations. If one considered only thoracic aortic
aneurysms, 12% of 386 thoracic specimens had idiopathic
From the Division of General Surgery, Mayo Clinic.
Competition of interest: none.
Reprint requests: Fernando Cordera, MD, Division of General Surgery,
Mayo Clinic, 200 First St SW, Rochester, MN 55905 (e-mail:
cordera.fernando@mayo.edu).
0741-5214/$30.00
Copyright © 2005 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2005.03.033
168inflammatory features.5 Noninfectious aortitis may occur in
isolation or as part of a systemic inflammatory disorder such
as Takayasu arteritis, systemic lupus erythematosus, rheu-
matoid arthritis, and giant cell arteritis.6-9 Aortitis has not
yet been reported in patients with MFS.
We report the case of a 32-year-old man with MFS and
a strong family history of aneurysmal disease who presented
with an asymptomatic aneurysm that involved the abdom-
inal aorta from the level of the diaphragm to the aortic
bifurcation (Crawford type IV).2 This aneurysm had no
associated dissection. Surgical pathology revealed severe
medial degeneration characterized by elastic tissue loss and
lymphoplasmacytic aortitis. To our knowledge, this is the
first report of such a finding in a patient with MFS.
CASE REPORT
The patient presented is a 32-year-old man who was diag-
nosed with MFS at age 3. He had a strong family history of both
ascending and descending aortic aneurysms. He had been carefully
followed since childhood and 16 months before presentation, an
ultrasound scan of the abdomen identified a 4-cm abdominal aortic
aneurysm. Four months later, a computed tomography (CT) scan
of the abdomen revealed a fusiform infrarenal aneurysmmeasuring
5.2 cm. At the time of the presentation, a CT scan confirmed a
5.9-cm aneurysm that extended from the level of the diaphragm to
the aortic bifurcation, consistent with a Crawford type IV thora-
coabdominal aortic aneurysm. His medical history was significant
for multiple sclerosis, depression, and bilaterally displaced lenses,
and he met the diagnostic criteria forMFS. His surgical history was
significant only for a tonsillectomy. His father and two paternal
aunts had undergone open surgical repair of aortic aneurysms
before age 55 (ascending and abdominal, ascending, and thoraco-
abdominal, respectively). One of these aunts and her two children
had been diagnosed with MFS. On physical examination, he had
the typical features of MFS. His height was 6 ft 5 in. A prominent
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upper and lower extremity pulses were all normal. Laboratory
studies were remarkable only for a white blood cell count of 5.5
109/L (normal range, 3.510.5  109/L) with 0.71  109/L
lymphocytes (normal range, 0.9 –2.9 109/L). Because there was
no reason to suspect a vasculitic disorder, autoimmune serologic
studies and markers of inflammation were not obtained. His pre-
operative evaluation included a transthoracic echocardiogram that
showed findings consistent with MFS. These consisted of mild
ascending aortic dilatation (37 mm) and mitral valve prolapse with
amildly thickenedmitral valve with trivial regurgitation. The aortic
valve and left ventricle were normal. A CT scan of the chest and
abdomen identified a thoracoabdominal aortic aneurysm with a
diameter of 59 mm.
His type IV thoracoabdominal aortic aneurysm was repaired
with the insertion of a 22  11-mm bifurcated, gelatin-coated
polyester graft from the level of the diaphragm to both mid
common iliac arteries. Two pairs of intercostal arteries, the celiac
and the superior mesenteric arteries, and the right renal artery were
incorporated with an aortic cuff into the proximal anastomosis.
The left renal artery was revascularized using a 7-mm interposition
gelatin-coated polyester graft (Fig 1). Cerebrospinal fluid drainage
was used during the procedure. The patient tolerated the proce-
dure well, and his postoperative recovery was uneventful. He was
dismissed on the sixth postoperative day. Surgical pathology re-
vealed lymphoplasmacytic aortitis and medial degeneration com-
posed mainly of diffuse and severe loss of elastic fibers without
pooling of proteoglycans (Figs 2 and 3). Six months after the
procedure, the patient is completely asymptomatic and has re-
Fig 1. Intraoperative image illustrates the bifurcated, ge
both mid common iliac arteries.sumed his normal activities.DISCUSSION
Approximately 6.3% of all TAAs requiring surgical in-
tervention are associated with MFS.1 Half of these aneu-
rysms (50%) involve the descending thoracic and most of
the abdominal (Crawford type II), and the majority
(80%) are associated with an aortic dissection.1 CMD is
the usual histologic finding in aortic aneurysms in patients
with MFS and is also noted commonly in thoracic aneu-
rysms in patients without MFS.4
The patient presented stands out in that he had a type
IV aneurysm, with no associated dissection and lymphop-
lasmacytic aortitis, which has not yet been reported inMFS.
The simultaneous occurrence of these findings could
be simply coincidental; however, we believe that the iden-
tified aortitis suggests that an autoimmune process may
play a role in this somewhat atypical aneurysm in a patient
who carries the diagnosis of multiple sclerosis, which itself is
considered an autoimmune disease characterized by im-
mune-initiated inflammatory demyelination of nerve fibers.
The typical histologic lesion in the aortic tissue of
patients with MFS, CMD is characterized mainly by the
degeneration of elastic fibers in the medial layer of the aorta
with variable accumulation of pools of glycosaminoglycans.
CMD is not a specific finding of MFS and can be seen in
other heritable disorders of connective tissue, such as the
Ehlers-Danlos syndrome.10 It is also seen in patients with-
out inherited connective tissue disease and may be associ-
ated with certain risk factors such as systemic hypertension
coated polyester graft from the level of the diaphragm tolatin-and bicuspid aortic valve. In patients with inherited con-
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of medial inflammation (Verhoeffvan Gieson stain, 100).Fig 3. Multiple scattered foci of medial inflammation composed mainly of lymphocytes, plasma cells, and histiocytes
without multinucleated giant cells are also identified, defining lymphoplasmacytic aortitis (hematoxylin and eosin,
200).
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usually greater in extent and severity.10
Aortitis is less common than CMD and is seen in approx-
imately 16% of all ascending and TAAs that require surgical
intervention.4,5 The most common subtype of aortitis is giant
cell aortitis.10 Lymphoplasmacytic aortitis is much less com-
mon and is characterized by medial inflammation composed
of lymphocytes and plasma cells without giant cells or granu-
lomas.8 Patients with aortitis have a significantly higher inci -
dence of autoimmune disease when compared with controls
(19% vs 0%).5 Aortitis may occur in isolation or as part of a
systemic inflammatory disorder such as Takayasu arteritis,
systemic lupus erythematosus, rheumatoid arthritis, and giant
cell arteritis.5-9 Aortitis has not been described in MFS. Al-
though the patient presented here had multiple sclerosis,
which is often considered an autoimmune process, aortitis has
not been associated with it.
In our patient, CMD was mostly characterized by
fragmentation and loss of elastic fibers without significant
accumulation of glycosaminoglycans. The loss of elastic
tissue was not limited to the areas of medial inflammation
and extended to other areas of the specimen, indicating that
this process was not localized and involved the entire aorta
and implying a more systemic process.
Treatment of aneurysms with associated aortitis is not
different from that of other aneurysms. Although patients
with MFS occasionally require more extensive operations,
several studies have shown that aortic reconstruction for
both patients with Marfan-related aneurysms and patients
with aortitis can be performed safely. Indications, treat-
ment, and prognosis of both patient groups are the same
when compared with those of other patients with aortic
aneurysms.11,12
The role of medical treatment of aortitis-related aneu-
rysms with immunosuppressive therapy remains uncertain.
In a recent retrospective study, 36 patients with follow-up
of more than 42 months after aortic surgery, new aneu-
rysms were identified in 6 of 25 patients who were not
treated with glucocorticosteroids and in none of 11 pa-
tients who were treated with glucocorticosteroids.5 Al-
though the observations could indicate a benefit of such
therapy in this setting, marked variation of dose and dura-
tion of therapy raises uncertainty about the efficacy of
therapy and such therapy may outweigh the hypothetical
benefit of preventing progression or recurrence of the
inflammatory process. Because 17% of patients subse-
quently developed new aneurysms, patients with aortitis-
associated aneurysms should be periodically evaluated for
recurrent disease and immunosuppressive treatment should
be considered on an individual basis.
Patients with MFS often require new surgical interven-
tions after undergoing aortic operations. In a study de-
signed to determine long-term results of aortic surgery,
101 of 192 (52.6%) patients required a second operation to
repair aneurysms that developed at a different site.13In our patient, the strong family history of aneurysmal
disease and the development of thoracoabdominal aneurysm
in three close relatives suggest a genetic component to his
aneurysm formation. Because patients with aortitis and pa-
tients with MFS have a higher risk of recurrence, the risk of
recurrence in this particular patient and his family may be
much higher than of other patients with MFS. We are plan-
ning to follow this patient and his family very closely for the
development of new aneurysms andwill attempt to determine
whether other aneurysms also have evidence of aortitis.
CONCLUSIONS
This case represents the first reported case of lymphop-
lasmacytic aortitis in a patient with MFS. It illustrates a
young patient with an uncommon problem in which surgi-
cal treatment resulted in a good outcome. The coincidence
of aortitis and MFS may place this patient at higher risk of
aneurysm recurrence when compared when other patients
with MFS. Further genetic and biochemical studies may
lead to better understanding of the pathogenesis of aortic
aneurysm in similar patients.
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